Non-invasive Ventilation in Patients With Interstitial Lung Disease - a Feasibility Study
NCT ID: NCT02377739
Last Updated: 2019-02-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2015-02-28
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Nocturnal Non-invasive Ventilation in Stable COPD
NCT03053973
Non-invasive Ventilation in Severe Chronic Obstructive Pulmonary Disease(COPD)
NCT00710541
Course and Complications of Invasive Out-of-hospital Ventilation
NCT01755039
Non Invasive Mechanical Ventilation in Chronic Respiratory Insufficiency Patients During Rehabilitation
NCT01458314
Deventilation Dyspnea in COPD Patients Using NIV
NCT03503123
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
non-invasive ventilation
patients will undergo about 14 nights of non-invasive ventilation during pulmonary rehabilitation
non-invasive ventilation
patients will undergo a nocturnal non-invasive ventilation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
non-invasive ventilation
patients will undergo a nocturnal non-invasive ventilation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hypercapnia defined as carbon dioxide partial pressure ≥45 mmHg (at rest, night or activity)
* already existing but not sufficient and regular use of non-invasive ventilation (≤3h/24h)
* patients consent to participate in this trial
Exclusion Criteria
* acute, clinically relevant heart disease
* already existing and sufficient use of non-invasive ventilation (≥3h/24h)
* Body-Mass-Index\>30
* obstructive sleep apnea
* Intolerance to perform non-invasive ventilation
* acute infection
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Weinmann Geräte für Medizin GmbH + Co. KG
INDUSTRY
Schön Klinik Berchtesgadener Land
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Klaus Kenn
Dr. med. Klaus Kenn
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Klaus Kenn, MD
Role: PRINCIPAL_INVESTIGATOR
Schoen Klinik Berchtesgadener Land
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Schoen Klinik Berchtesgadener Land
Schönau am Königssee, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIV-ILD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.